Skip to main content
Pixium Vision logo

Pixium Vision — Investor Relations & Filings

Ticker · ALPIX ISIN · FR001400JX97 LEI · 96950046OPLRLKKEOO08 PA Manufacturing
Open in API
Filings indexed 440 across all filing types
Latest filing 2023-03-31 Regulatory Filings
Country FR France
Listing PA ALPIX

About Pixium Vision

https://www.pixium-vision.com/

Pixium Vision was a bioelectronics company that developed bionic vision systems to restore partial sight for patients with retinal diseases. Its core technology, the PRIMA System, is a photovoltaic subretinal implant designed to treat vision loss from advanced atrophic dry age-related macular degeneration (dry AMD). The system uses specialized glasses to project near-infrared light onto the implant, which converts the light into electrical signals to stimulate retinal cells and create a form of prosthetic vision. The company's assets, including the PRIMA technology and its ongoing European pivotal trial (PRIMAvera), were acquired by Science Corporation in late 2023. The trials and device manufacturing are now sponsored by La Science SAS.

Recent filings

Filing Released Lang Actions
Breakthrough Device Designation FR
Regulatory Filings Classification · 100% confidence The document is a press release dated March 31, 2023, announcing that Pixium Vision's Prima System has received 'Breakthrough Device' status from the US FDA for treating dry Age-related Macular Degeneration (AMD). This announcement details regulatory progress, clinical trial timelines (PRIMAvera study), and potential future market access benefits. It is not a full financial report (10-K or IR), an earnings release (ER), a proxy statement (DEF 14A), or a transcript (CT). Since it is a specific, non-financial regulatory/clinical milestone announcement that doesn't fit the other specific categories (like DIRS, DIV, CAP, etc.), it falls best under the general 'Regulatory Filings' (RNS) category, which serves as a broad category for significant corporate news that isn't strictly financial reporting or management change. Given the nature of the announcement (FDA status), it is a significant regulatory event update.
2023-03-31 French
Réduction du capital social motivée par des pertes par réduction de la valeur nominale: nombre d’actions inchangé
Share Issue/Capital Change Classification · 99% confidence The document explicitly announces a reduction in share capital ('Réduction du capital social') due to losses, achieved by reducing the nominal value of shares. This action directly impacts the company's capital structure. Based on the definitions, this falls under 'Capital/Financing Update' (CAP), as it details a change in the capital structure, even though it is described as 'purely technical' and does not change the number of shares outstanding. It is not an earnings release, an annual report, or a dividend notice.
2023-03-17 French
Reduction of share capital due to losses by reduction of nominal value: number of shares unchanged
Share Issue/Capital Change Classification · 99% confidence The document explicitly details a decision by the Board of Directors to reduce the company's share capital by reducing the nominal value of each share due to losses. This action directly impacts the company's capital structure. Based on the provided definitions, this falls under 'Capital/Financing Update' (Code: CAP), as it involves a change in the capital structure, even if the number of shares remains unchanged. It is not a general regulatory filing (RNS) or a report publication announcement (RPA) because it contains the substantive details of the capital change itself, rather than just announcing that a report is available.
2023-03-17 English
Results of Extraordinary Shareholders Meeting held on March 8, 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Results of Extraordinary Shareholders Meeting held on March 8, 2023" and details the adoption of several resolutions by the shareholders, including capital reduction and reverse stock split authorizations. This content directly relates to the outcomes and results of a shareholder vote at a general meeting. Therefore, the most appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA). The document is a formal announcement of these results, not a proxy solicitation (PSI) or a general AGM presentation (AGM-R).
2023-03-10 English
Assemblée Générale Extraordinaire du 8 mars 2023 résultats
AGM Information Classification · 99% confidence The document is titled "COMMUNIQUE DE PRESSE" and explicitly discusses the results of the "Assemblée Générale Extraordinaire du 8 mars 2023" (Extraordinary General Meeting of March 8, 2023). It details that the shareholders adopted resolutions related to capital reduction and share consolidation. This content directly relates to shareholder voting outcomes and meeting results. The most specific category for official results from shareholder votes at any general meeting is 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it is a press release, the core subject matter is the voting results, making DVA more precise than a general RPA or RNS.
2023-03-10 French
Assemblée Générale Extraordinaire du 8 mars 2023 : Modalités de mise à disposition des documents préparatoires
AGM Information Classification · 98% confidence The document is a formal announcement dated February 28, 2023, regarding the modalities for making preparatory documents available for an Extraordinary General Meeting (Assemblée Générale Extraordinaire) scheduled for March 8, 2023. It explicitly mentions the publication of notices in official bulletins (BALO) and refers to the procedures for shareholders to consult documents related to the AGM. This content directly relates to the logistics and information dissemination surrounding a shareholder meeting, which aligns perfectly with the definition of AGM Information (AGM-R). Although it announces the meeting, the core content is about the meeting's documentation and procedures, making AGM-R more specific than a general Report Publication Announcement (RPA).
2023-02-28 French

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.